GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CK Life Sciences Intl (Holdings) 775.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.54

+1.90%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2025

Revenue

HK$5.41bn

FY2016FY2025

Net income

−HK$188.4m

FY2016FY2025

Free cash flow

−HK$277.8m

FY2016FY2025

Shareholders' equity

HK$3.78bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueHK$5.41bnHK$5.52bnHK$5.32bnHK$5.28bnHK$5.40bnHK$4.94bnHK$4.97bnHK$5.23bnHK$4.69bnHK$4.87bn
Gross profitHK$785.4mHK$1.69bnHK$1.64bnHK$1.63bnHK$1.63bnHK$1.41bnHK$1.61bnHK$1.73bnHK$1.54bnHK$1.66bn
Research and developmentHK$320.6mHK$254.1mHK$145.9mHK$158.5mHK$157.3mHK$149.8mHK$122.3mHK$151.8mHK$174.3mHK$170.5m
Operating incomeHK$227.7mHK$783.1mHK$391.0mHK$219.5mHK$334.9mHK$84.8mHK$376.3mHK$555.7mHK$423.8mHK$475.4m
Net income−HK$188.4m−HK$126.6mHK$17.3mHK$132.0mHK$162.8mHK$125.2mHK$181.7mHK$263.0mHK$258.4mHK$252.0m
Diluted earnings per share-0.02-0.010.000.010.020.010.020.030.030.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsHK$11.84bnHK$10.79bnHK$11.25bnHK$11.27bnHK$11.73bnHK$11.98bnHK$10.71bnHK$10.44bnHK$10.58bnHK$9.54bn
Cash and short-term investmentsHK$603.1mHK$571.2mHK$676.2mHK$704.1mHK$902.5mHK$971.7mHK$713.1mHK$785.0mHK$1.05bnHK$877.5m
Total liabilitiesHK$7.99bnHK$7.28bnHK$7.06bnHK$7.11bnHK$7.23bnHK$7.26bnHK$6.54bnHK$6.02bnHK$5.83bnHK$5.08bn
DebtHK$6.62bnHK$6.10bnHK$5.93bnHK$5.95bnHK$6.21bnHK$6.19bnHK$5.63bnHK$4.82bnHK$4.60bnHK$4.03bn
Shareholders' equityHK$3.78bnHK$3.51bnHK$4.19bnHK$4.16bnHK$4.50bnHK$4.72bnHK$4.18bnHK$4.26bnHK$4.62bnHK$4.26bn
Shares outstanding9,629m9,611m9,611m9,611m9,611m9,611m9,611m9,611m9,611m9,611m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−HK$32.8mHK$353.5mHK$514.2mHK$363.7mHK$423.6mHK$531.0mHK$379.1mHK$230.7mHK$134.6mHK$438.9m
Capital spending−HK$245.0m−HK$196.5m−HK$291.8m−HK$217.0m−HK$217.2m−HK$379.8m−HK$197.8m−HK$287.8m−HK$94.5m−HK$210.1m
Free cash flow−HK$277.8mHK$157.0mHK$222.4mHK$146.7mHK$206.3mHK$151.1mHK$181.4m−HK$57.1mHK$40.1mHK$228.9m
Dividends paid——−HK$76.9m−HK$96.1m−HK$96.1m−HK$96.1m−HK$96.1m−HK$96.1m−HK$96.1m−HK$86.5m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueHK$2.72bnHK$2.80bnHK$2.61bnHK$2.89bnHK$2.64bnHK$2.74bnHK$2.58bnHK$2.74bn
Gross profitHK$372.9mHK$366.4mHK$793.6mHK$893.1mHK$799.4mHK$491.5mHK$456.2mHK$533.4m
Operating incomeHK$86.0m−HK$97.3mHK$226.7mHK$374.6mHK$408.4mHK$100.0mHK$123.9mHK$108.2m
Net income−HK$28.7m−HK$37.6m−HK$150.8m−HK$127.6mHK$1.0m−HK$19.7mHK$36.9mHK$66.8m
Diluted earnings per share-0.00-0.00-0.02-0.010.00-0.000.000.01
Cash from operations−HK$50.0m−HK$26.0m−HK$6.0mHK$208.0mHK$145.0mHK$433.0mHK$80.0mHK$15.0m
Capital spending—−HK$244.0m—−HK$196.0m—−HK$287.0m——
Free cash flow—−HK$270.0m—HK$12.0m—HK$146.0m——
Total assetsHK$12.16bnHK$11.84bnHK$11.29bnHK$10.79bnHK$10.89bnHK$11.25bnHK$11.05bnHK$11.27bn
Cash and short-term investmentsHK$535.7mHK$603.1mHK$797.8mHK$571.2mHK$562.1mHK$676.2mHK$505.9mHK$704.1m
DebtHK$2.53bnHK$6.62bnHK$6.50bnHK$6.10bnHK$5.95bnHK$5.93bnHK$5.94bnHK$5.95bn
Shareholders' equityHK$3.95bnHK$3.78bnHK$3.65bnHK$3.51bnHK$4.01bnHK$4.19bnHK$4.17bnHK$4.16bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.8%1.8%1.0%
Operating income1.2%21.9%-5.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin22.7%26.7%27.5%30.2%
Operating margin9.2%7.5%6.4%7.6%
Net margin-2.9%-0.8%0.4%2.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-41.9-31.1345.457.543.767.546.013.322.326.3
Price to sales1.50.71.11.41.31.71.70.71.21.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 23 May 2023.

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Paid in the year0.0080.010.010.010.010.010.010.009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.